This inventor holds 1 USPTO granted patent. Top assignees: Oncolys Biopharma, Inc., Toshiyuki Sakai. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 5 
1 out of 2 Years Active: 2006
Title: Innovations of Yoshikazu Sukenaga
Introduction
Yoshikazu Sukenaga is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of biotechnology, particularly in cancer research. His work focuses on the development of genetic tools that can aid in the diagnosis and treatment of diseases.
Latest Patents
Yoshikazu Sukenaga holds a patent for a gene encoding the promoter domain of the tumor suppressor gene P51. This invention provides a gene capable of inducing cell death, which is crucial in combating cancer caused by abnormal cell propagation. The patent also includes antisense DNAs and RNAs, nucleic acid probes, and methods for detecting these genes, which are essential for drug screening and disease diagnosis.
Career Highlights
Throughout his career, Sukenaga has worked with notable companies, including Oncolys Biopharma, Inc. His innovative research has positioned him as a key figure in the biotechnology sector, contributing to advancements in cancer treatment.
Collaborations
Yoshikazu Sukenaga has collaborated with esteemed colleagues such as Toshiyuki Sakai and Hideji Fujii. These partnerships have fostered a collaborative environment that enhances research and development in the field.
Conclusion
Yoshikazu Sukenaga's work exemplifies the impact of innovation in biotechnology, particularly in the fight against cancer. His contributions through patents and collaborations continue to influence the medical field significantly.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile